small molecule

RESCULA

UNOPROSTONE ISOPROPYL

Loss of exclusivity—loss of exclusivity

CompanySUCAMPO PHARMA AMERICAS LLC

Drug detail

Brand name	RESCULA
Active ingredient	UNOPROSTONE ISOPROPYL
Strength	0.15% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons
Dosage form	SOLUTION/DROPS
Route	OPHTHALMIC
Modality	Small molecule
FDA approval	August 2000
Marketing status	DISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.